Disease, iPSCs and a Quest for the Perfect Model

Disease, iPSCs and a Quest for the Perfect Model

Bibliographic Details
Format:	Article
Language:	English
Published:	Elsevier 2016-02-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S235239641630038X

Similar Items

iPSCs are safe!
by: Hualong Yan, et al.
Published: (2017-05-01)

iPSCs in Modeling and Therapy of Osteoarthritis
by: Maria Csobonyeiova, et al.
Published: (2021-02-01)

Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-01-01)

Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-07-01)

Phenotyping Neurodegeneration in Human iPSCs
by: Li, Jonathan, et al.
Published: (2021)

Parallel derivation of X-monosomy induced pluripotent stem cells (iPSCs) with isogenic control iPSCs
by: Anis Feki, et al.
Published: (2020-08-01)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient <i>in vitro</i> Clearance of iPSCs and iPSC-Macrophages
by: Alexandra Lipus, et al.
Published: (2020-04-01)

Recent Overview of the Use of iPSCs Huntington’s Disease Modeling and Therapy
by: Maria Csobonyeiova, et al.
Published: (2020-03-01)

iPSCs and Exosomes: Partners in Crime Fighting Cardiovascular Diseases
by: Giulia Germena, et al.
Published: (2021-06-01)

Differentiation of human iPSCs into functional podocytes.
by: Caroline Rauch, et al.
Published: (2018-01-01)

iPSCs: From Bench to Clinical Bed
by: Yujing Li, et al.
Published: (2016-01-01)

Células Estaminais Pluripotentes Induzidas (iPSCs)
by: Mariana da Costa Santos Coelho Freitas
Published: (2019)

Contribuction of human iPSCs to the study of neuron development and disease modelling in vivo
by: Raquel Maria Coelho Real
Published: (2020)

Generation and characterization of Angelman Syndrome iPSCs for disease modelling and drug screening
by: Duarte Pólvora Brandão
Published: (2019)

Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology
by: Sahar Avazzadeh, et al.
Published: (2021-03-01)

The State of Play with iPSCs and Spinal Cord Injury Models
by: Stuart I. Hodgetts, et al.
Published: (2015-01-01)

Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
by: Haupt, Luis Peter
Published: (2018)

The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside
by: Nina Xie, et al.
Published: (2016-01-01)

Establishment of Human iPSCs differentiated Mature Retinal Ganglion Cells Platform: Using HiPSCs-RGCs as Disease Models
by: Ke-Hung Chien, et al.
Published: (2018)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
by: Claudia Compagnucci, et al.
Published: (2017-11-01)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
by: Ava C. Carter, et al.
Published: (2014-02-01)

Broader Implications of Defining Standards for the Pluripotency of iPSCs
by: Daley, George Q., et al.
Published: (2015)

Establishing iPSCs as a method to model neurodevelopment in Down’s syndrome
by: Bartish, Margarita
Published: (2012)

Modelling urea-cycle disorder citrullinemia type 1 with disease-specific iPSCs
by: Uebayashi(Yoshitoshi), Elena Yukie
Published: (2017)

Induced pluripotent stem cells (iPSCs) for research and therapy : induction of hepatic differentiation in iPSCs and evaluation of their quality as a model of in vivo development in the context of coagulation
by: Caxaria, Sara
Published: (2016)

Modeling leukemia with pediatric acute leukemia patient-derived iPSCs
by: Ting Li, et al.
Published: (2021-07-01)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
by: Nikita Arnst, et al.
Published: (2021-07-01)

Microhomology-assisted scarless genome editing in human iPSCs
by: Shin-Il Kim, et al.
Published: (2018-03-01)

Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells
by: Pooja Hor, et al.
Published: (2020-09-01)

Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
by: Eunhye Kim, et al.
Published: (2016-09-01)

An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
by: Siddharth Menon, et al.
Published: (2016-01-01)

Pannexin 1 Influences Lineage Specification of Human iPSCs
by: Rebecca J. Noort, et al.
Published: (2021-04-01)

Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson’s disease carrying the I2020T mutation in LRRK2
by: Etsuro Ohta, et al.
Published: (2020-12-01)

Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs
by: Lina Fu, et al.
Published: (2016-02-01)

Application of Patient-Specific iPSCs for Modelling and Treatment of X-Linked Cardiomyopathies
by: Jennifer Zhang, et al.
Published: (2021-07-01)

Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
by: James Hawrot, et al.
Published: (2020-02-01)

Versatility of Induced Pluripotent Stem Cells (iPSCs) for Improving the Knowledge on Musculoskeletal Diseases
by: Clara Sanjurjo-Rodríguez, et al.
Published: (2020-08-01)

Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts
by: Reza Rikhtegar, et al.
Published: (2019-01-01)

Corneal cell therapy: with iPSCs, it is no more a far-sight
by: Koushik Chakrabarty, et al.
Published: (2018-10-01)

iPSCs: A Preclinical Drug Research Tool for Neurological Disorders
by: Gabriele Bonaventura, et al.
Published: (2021-04-01)